ResultsIQ

ResultsIQ › Latest results › Excel Industries Limited

Excel Industries Limited Q2 FY26 results deck summary

NSE: EXCELINDUS · BSE: 500650

Results deck of 14 Nov 2025, summarised by AI from the filing.

New 5-year contract manufacturing agreement for a specialty chemical product with revenue potential of ₹35-40 cr p.a.

Key takeaways

  1. New contract manufacturing New 5-year contract manufacturing agreement for a specialty chemical product with revenue potential of ₹35-40 cr p.a.
  2. Biocide capacity New capacity for one of the biocides manufactured by the company has come on stream in Oct-25.

Original filing on BSE

Excel Industries Limited Q1 FY27 results

As filed: Revenue ₹294 cr (−5% year on year), EBITDA ₹42.4 cr (+1% year on year), PAT ₹29.5 cr (−13% year on year), EBITDA margin 14.4% (+89 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹281 cr (+13% year on year), EBITDA ₹22.0 cr (+16% year on year), PAT ₹12.3 cr (+2% year on year), EBITDA margin 7.8% (+15 bps). Score 33 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA growth was below it; profit growth was well below it. EBITDA margin rose 15 bps year on year. Share price after the results: −7.2% in 28 days (Nifty 500: +2.2%).
  • Q3 FY26: Revenue ₹234 cr (+19% year on year), EBITDA ₹15.7 cr (+31% year on year), PAT ₹8.4 cr (+41% year on year), EBITDA margin 6.7% (+62 bps). Score 39 of 100, Below trend. Revenue growth was above the company's own trend; EBITDA and profit growth were below it. EBITDA margin rose 62 bps year on year. Other income 46% of PBT. Profit rose ₹2.4 cr on a year ago, against ₹3.0 cr the year before. Share price after the results: −3.6% in 30 days (Nifty 500: −3.2%).
  • H1 FY26: Revenue ₹580 cr, EBITDA ₹73.0 cr, PAT ₹52.0 cr, EBITDA margin 12.6%. Not scored. No result for the same half-year last year. Share price after the results: −14.3% in 30 days (Nifty 500: −0.6%).
  • Q1 FY26: Revenue ₹310 cr (+17% year on year), EBITDA ₹42.0 cr (+5% year on year), PAT ₹34.0 cr (+10% year on year), EBITDA margin 13.6% (−155 bps). Score 43 of 100, In line with trend. Revenue growth was above the company's own trend; EBITDA and profit growth were below it. EBITDA margin fell 155 bps year on year. Other income 27% of PBT. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: −0.7% in 28 days (Nifty 500: +1.7%).
  • Q4 FY25: Revenue ₹248 cr (+6% year on year), EBITDA ₹19.0 cr (+58% year on year), PAT ₹12.0 cr (+71% year on year), EBITDA margin 7.7% (+253 bps). Score 55 of 100, In line with trend. Revenue growth was in line with the company's own trend; EBITDA and profit growth were below it. EBITDA margin rose 253 bps year on year. Other income 38% of PBT. Revenue grew on the previous quarter, against its usual seasonal pattern. Profit rose ₹5.0 cr on a year ago, against ₹5.0 cr the year before. Share price after the results: +9.8% in 28 days (Nifty 500: +3.3%).
  • Q3 FY25: Revenue ₹196 cr (+9% year on year), EBITDA ₹12.0 cr (+300% year on year), PAT ₹6.0 cr (+100% year on year), EBITDA margin 6.1% (+501 bps). Score 43 of 100, In line with trend. Revenue growth was in line with the company's own trend; EBITDA growth was above it; profit growth was below it. EBITDA margin rose 501 bps year on year. Other income 63% of PBT. Tax rate 38%. Profit lagged EBITDA because of depreciation, interest or other income, not the business. Revenue fell 27% from last quarter.
  • Q2 FY25: Revenue ₹269 cr (+36% year on year), EBITDA ₹49.0 cr (+300% year on year), PAT ₹36.0 cr (+300% year on year), EBITDA margin 18.2% (+1,000 bps). Score 96 of 100, Above trend. EBITDA margin rose 1000 bps year on year. Not enough history for a trend yet: scored on growth alone.

Past price moves after results do not indicate future moves. Not a recommendation.

Excel Industries Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.